Spironolactone for hormonal acne: how it works, who it's for, and what to expect
A complete guide to spironolactone for hormonal acne — androgen receptor blockade mechanism, clinical evidence, who is a candidate, side effects, monitoring requirements, and how it compares to oral contraceptives and isotretinoin.
· By MedSpot Editorial · 5 min read
Spironolactone is the most underutilized treatment for hormonal acne in adult women — and increasingly one of the most prescribed. For the right patient, it addresses the root hormonal driver of acne rather than its symptoms. Here's what you need to know.
What spironolactone is
Spironolactone is a potassium-sparing diuretic and aldosterone antagonist originally developed for cardiovascular disease and fluid retention. Its use in acne derives from a secondary property: it blocks androgen receptors in the skin, reducing the hormonal stimulation of sebaceous glands.
Off-label status: Spironolactone is not FDA-approved specifically for acne — it is used off-label for this indication. However, it has decades of published evidence and is a standard-of-care treatment in dermatology for hormonal acne in women.
Not used in male patients: Spironolactone's anti-androgenic effects cause feminizing side effects (gynecomastia, sexual dysfunction) that preclude routine use in males. Essentially all published acne evidence and clinical use is in female patients.
How spironolactone works for acne
Androgen receptor blockade in sebaceous glands
Androgens — particularly dihydrotestosterone (DHT) and testosterone — bind to androgen receptors in sebaceous glands, stimulating:
- Sebocyte (sebum-producing cell) proliferation
- Sebum production volume
- Sebaceous gland enlargement
Spironolactone competitively blocks androgen receptors in sebocytes — occupying the receptor without activating it, preventing DHT and testosterone from binding. Less androgen stimulation → less sebum → less comedone formation → less acne.
5-alpha reductase inhibition (secondary)
Spironolactone also weakly inhibits 5-alpha reductase — the enzyme that converts testosterone to the more potent DHT in peripheral tissues. Less DHT available → less receptor stimulation.
The hormonal acne pattern
Spironolactone is specifically effective for hormonal acne — characterized by:
- Distribution: lower face, jawline, chin, neck
- Timing: premenstrual flares (worse in the week before menstruation)
- Patient profile: adult women (typically 25–45), often with normal serum hormone levels
- Persistence despite antibiotics or topical retinoids
Women with hormonal acne often have normal serum androgen levels — the problem is sebaceous gland sensitivity to androgens, not androgen excess. Spironolactone addresses gland-level sensitivity regardless of circulating androgen levels.
Clinical evidence
Acne efficacy
Charny et al. (2017, Journal of the American Academy of Dermatology) — a large retrospective study of 403 women treated with spironolactone for acne found 66% achieved "clear" or "almost clear" status, with significant improvements across all acne subtypes.
Grandhi & Alikhan (2017, Dermatology) — a systematic review of 10 studies (n=1,727 female patients) found spironolactone produced significant acne improvement in 75–90% of patients, with dose-dependent effect.
Roberts et al. (2021, British Journal of Dermatology) — the SISTA trial, a large UK multicenter RCT (n=410), confirmed spironolactone 50–100 mg/day significantly outperformed placebo for acne at 24 weeks with an acceptable safety profile.
Dosing
| Dose | Use | Notes |
|---|---|---|
| 25 mg/day | Starting dose for very sensitive patients | Below typical therapeutic range |
| 50 mg/day | Standard starting dose | Effective for many patients |
| 75–100 mg/day | Most common effective range | Dose-dependent improvement up to 100 mg |
| 150–200 mg/day | Maximum for severe cases | Higher side effect rate |
Most dermatologists start at 50 mg/day and increase to 100 mg after 2–3 months if response is inadequate. The 100 mg dose has the best evidence-to-side-effect ratio.
Timeline: 3–6 months for full effect. Unlike antibiotics, spironolactone is safe for long-term continuous use.
Side effects and monitoring
Common side effects
- Menstrual irregularity: The most common complaint — cycle changes, spotting, or heavier periods. Often resolves with continued use; concurrent OCP use stabilizes cycles.
- Breast tenderness: Occurs in some patients, particularly at higher doses.
- Increased urination: Diuretic effect, particularly in first weeks. Mild and usually transient.
- Fatigue or dizziness: At higher doses; usually resolves with dose adjustment.
- Hyperkalemia (elevated potassium): The most significant medical concern.
Hyperkalemia risk
Spironolactone blocks aldosterone → reduces urinary potassium excretion → can elevate serum potassium. In young, healthy women with no kidney disease, this risk is very low:
Plovanich et al. (2015, JAMA Dermatology) — a large cohort study of women <45 with no renal disease or potassium-altering medications found hyperkalemia rate of 0% in young healthy women on spironolactone for acne. The study questioned the necessity of routine potassium monitoring in this population.
When monitoring IS warranted:
- Age >45
- Renal impairment
- Diabetes mellitus
- Concurrent use of ACE inhibitors, ARBs, NSAIDs, or other potassium-sparing drugs
- Dietary potassium supplements
For a typical healthy woman in her 30s on spironolactone 100 mg for acne, many dermatologists no longer routinely monitor potassium — though baseline labs remain common practice.
Pregnancy contraindication
Spironolactone causes feminization of male fetuses in animal studies and is absolutely contraindicated in pregnancy. Women of childbearing potential must use reliable contraception. Many prescribers require concurrent OCP use.
Spironolactone vs. alternatives for hormonal acne
| Treatment | Mechanism | Evidence | Notes |
|---|---|---|---|
| Spironolactone | Androgen receptor blockade | Strong | Women only; 3–6 months onset; long-term safe |
| Combined oral contraceptives | Suppress ovarian androgen production | Strong (FDA-approved for acne) | Several OCPs FDA-approved for acne |
| Isotretinoin | Sebaceous gland reduction | Very strong | Severe cases; more intensive; teratogenic |
| Topical retinoids + antibiotics | Symptomatic; not hormonal mechanism | Strong | First-line but doesn't address root cause |
| Drospirenone OCP (Yaz) | Anti-androgenic progestin + estrogen | Strong (FDA-approved) | Good option when contraception also desired |
Combination: Spironolactone + oral contraceptive is a common combination — the OCP regulates menstrual irregularity from spironolactone, provides contraception (mandatory), and adds its own anti-androgenic effect.
Who is a good candidate
Ideal:
- Adult woman with jawline/chin acne pattern
- Premenstrual flares
- Acne persisting despite topical retinoids + topical antibiotics
- Acne recurring after antibiotic courses
- Patient who wants to avoid or who failed isotretinoin
Not appropriate:
- Male patients (feminizing side effects)
- Women trying to conceive or pregnant
- Patients with renal impairment or hyperkalemia
- Women who cannot tolerate or use contraception reliably
Accessing spironolactone via telehealth
Spironolactone for acne is commonly prescribed via telehealth dermatology platforms (Curology, Apostrophe, Hims/Hers for women, Nurx). A provider evaluation confirms candidacy, discusses contraception, and can manage dose adjustments without in-person visits.
Looking for a hormonal acne consultation? Browse skincare providers on MedSpot →